Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Effects of Alirocumab and Evolocumab on the outcomes and lipid profile of diabetic patients: Meta-analysis of randomized controlled trials.
Anno:
2023
Objective: To evaluate the specific effects of alirocumab and evolocumab on major cardiovascular events (MACE) and lipid profile in patients with diabetes. Methods: We conducted a systematic review of literature according to the PRISMA statement. A total of 8 randomized control trials (RCTs) enrolling 20651 patients with diabetes were included….
Leggi di più
PREVALENCE OF HYPOVITAMINOSIS D OVER THE YEARS AND ITS RELATIONSHIP WITH DIABETES MELLITUS AND ANEMIA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Anno:
2023
Background: Hypovitaminosis D is a common condition among patients with cardiovascular diseases and it is closely associated with inflammation, oxidative stress, endothelial dysfunction, diabetes mellitus (DM), insulin resistance and anemia. Aims and methods: We aim to assess the prevalence and persistence of hypovitaminosis D (<20 ng/ml) over years among 1510 patients…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram